Brazilian homegrown medtech given cause to celebrate
This article was originally published in Clinica
Executive Summary
A new healthcare product innovation programme, greater support for the adoption of international standards and new earmarked funds totalling R$7 billion (US$3.5 billion) are among a flurry of medtech development initiatives that have been unveiled in Brazil in support of homegrown developers and manufacturers.